In the August issue of Gut the following paper, Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less (S-M Lin, C-J Lin, C-C Lin, C-W Hsu, and Y-C Chen. Gut 2005;54:1151–1156), was published without one of the author corrections being made. On page 1154 under the heading “Local and new HCC recurrence”, the first line reads “…a median of 35 months“ and should have be revised to “…a median of 24.3 months“.